More on CORT
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $71.20 |
|
|||
| Open | $70.93 | ||||
| 52 Wk High | $10.00 | ||||
| 52 Wk Low | $3.22 | ||||
| Day High | $72.95 | ||||
| Day Low | $70.07 | ||||
| P/E | N/A | ||||
| EPS | $-0.46 | ||||
| Volume | 793,349 | ||||
- Form 8-K CORCEPT THERAPEUTICS For: May 19
- Form 4 CORCEPT THERAPEUTICS For: May 29 Filed by: BELANOFF JOSEPH K
- Form 144 CORCEPT THERAPEUTICS Filed by: Guyer William
- H.C. Wainwright Reiterates Buy Rating on Corcept Therapeutics (CORT)
- Form 144 CORCEPT THERAPEUTICS Filed by: Mokari Atabak
- Form 144 CORCEPT THERAPEUTICS Filed by: BELANOFF JOSEPH K
- Form 4 CORCEPT THERAPEUTICS For: May 27 Filed by: Lyon Joseph Douglas
- Form 4 CORCEPT THERAPEUTICS For: May 27 Filed by: Maduck Sean
- Form 4 CORCEPT THERAPEUTICS For: May 27 Filed by: WILSON JAMES N
- Corcept presents survival data for Lifyorli in ovarian cancer at ASCO
Entities mentioned with CORT
- FDA | View Related Stories »
- Earnings | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Show More...
